Please login to the form below
Lawsuits
This page shows the latest Lawsuits news and features for those working in and with pharma, biotech and healthcare.
California sues largest US insulin manufacturers and PBMs for overpricing
The lawsuit, filed in the California Superior Court in Los Angeles, argues that because competition is highly limited in both their markets, these six companies are able to keep ‘aggressively hiking’ ... With today's lawsuit, we're fighting back
Latest news
-
Teva and Allergan finalise terms of US opioid settlements worth $6.6bn combined
Teva Pharmaceuticals (Teva) and AbbVie’s Allergan branch have finalised the terms of nationwide settlements to resolve thousands of lawsuits in the US over the marketing of opioid painkillers, the companies ... US states, cities and counties have filed
-
Biogen to pay $900m to settle whistleblower’s MS drug kickback lawsuit
Biogen has reached a final agreement to pay $900m to resolve a whistleblower lawsuit accusing the biotech company of paying kickbacks to healthcare professionals (HCPs) to encourage them to prescribe multiple ... The US Department of Justice explained in
-
Moderna sues Pfizer/BioNTech over COVID-19 vaccine technology
The lawsuit, which seeks undetermined monetary damages, was filed in US District Court in Massachusetts, and in the Regional Court of Düsseldorf in Germany, Moderna said. ... BioNTech said in a statement that the work is original, calling the lawsuit
-
AbbVie’s Allergan reaches proposed $2.37bn agreement to settle US opioid lawsuits
AbbVie’s Allergan branch has agreed to pay up to $2.37bn to states and local governments to resolve the thousands of US lawsuits against its Allergan unit over the marketing ... The announcement follows Teva Pharmaceuticals (Teva) reaching a nationwide
-
Teva reaches proposed $4.25bn agreement to settle US opioid lawsuits
Teva Pharmaceutical (Teva) has reached a nationwide agreement in principle of up to $4.25bn to settle the thousands of lawsuits accusing it of fuelling the US opioid crisis, the company ... US states, cities and counties have filed thousands of lawsuits
More from news
Approximately 11 fully matching, plus 343 partially matching documents found.
Latest Intelligence
-
The new reality of building a corporate brand in pharma
For instance, when the weight loss drug, Fenphen was recalled in 1997, after a study revealed patients experienced heart disease and pulmonary problems, there were thousands of lawsuits filed by US
-
20 for 2020 – Five pharma companies to watch
year. We’re talking about the lawsuits J&J is facing claiming damages as a result of using its products, including opioid painkillers, Baby Powder talc and its schizophrenia drug Risperdal ... All told, J&J is facing tens of thousands of lawsuits, a
-
As the opioid crisis grabs the headlines, the search for safe treatments continues
Rising levels of drug use are barbed with the complexities of opioid dependence and wreathed with the unpredictable wildfires of lawsuits.
-
Deal Watch January 2018
investors. However, in the meantime the US Securities and Exchange Commission (SEC) has issued a lawsuit against some traders for insider trading based on a series of suspicious transactions that made
-
Market access improvements in Turkey
Industry successfully filed a lawsuit against the Ministry of Health for the lack of updates.
More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.
Latest from PMHub
-
WHITE PAPER: What's missing in women's health?
29. In the pharmaceutical industry, this is demonstrated by the recent surge in lawsuits against pharma companies for the poor regulation of vaginal meshes.
-
Article: The Colombia Conundrum
More than 346, 000 lawsuits of this nature were raised between 2006 and 2008, with courts usually deciding in favor of the patients. ... As the number of lawsuits increased exponentially in the following years, the healthcare system was plunged into
-
Clinical data Transparency
Amidst extensive criticism the pharmaceutical industry has called for more carrot as an incentive for companies to begin releasing their data; and in the face of two lawsuits even the European
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Roche’s Polivy recommended by NICE for lymphoma therapy
- ASH 2022: bad blood but big advances
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- AbbVie’s Rinvoq approved by MHRA for Crohn's disease
- GSK’s Benlysta given orphan drug status by FDA for systemic sclerosis
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Takeda’s dengue vaccine receives MHRA approval for those aged four years and older
- Sandoz’s biosimilar denosumab application accepted by FDA for osteoporosis
- Novartis’ Cosentyx shows continued improvement in hidradenitis suppurativa patients
- NHS urges people yet to receive their COVID-19 booster to come forward
- Biosimilars and beyond: innovating for improved patient outcomes
- Gilead’s Trodelvy approved by FDA for metastatic breast cancer
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- Why female mentorship is so powerful in pharma
- AbbVie and Eli Lilly leave UK’s voluntary drug pricing agreement
- Europe’s cancer community publishes new report on transforming patient care
- Digital technology: a significant change in healthcare innovation
- Assessing the value of interim analyses in clinical trials
PMHub
Langland
Langland, a Publicis Health company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy...
Latest intelligence
- Biosimilars and beyond: innovating for improved patient outcomes
- How Europe’s biosimilar landscape has rapidly evolved over the last two decades, bringing biological medicines to more patients than ever before...
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
- Strategic behaviour
- Strong strategising depends on your colleagues’ behaviour...
